Key result
Elevated plasma lnc-NEAT1 accurately discriminates coronary heart disease from controls with an AUC of ~0.87.
Why the study?
Lnc-NEAT1 regulates endothelial cell functions, CD4+ T cell regulation, and chronic inflammation related to CHD, but its clinical value in CHD management needed exploration.
Does lnc-NEAT1 expression correlate with disease severity, inflammatory cytokines, and Th17 cells in patients with coronary heart disease?
Case-Control (n=240)
No
Does lnc-NEAT1 expression correlate with disease severity, inflammatory cytokines, and Th17 cells in patients with coronary heart disease?
Effect estimate: AUC 0.866 (95% CI 0.822-0.910)
p-value: p=<0.001
Lnc-NEAT1 expression is elevated in patients with coronary heart disease and correlates with disease severity, inflammatory cytokines, and Th17 cells, suggesting its potential as a biomarker for CHD.
Supports lnc-NEAT1 as a potential noninvasive CHD biomarker; leaves open its clinical utility pending prospective validation.
Background Long non‐coding RNA nuclear enriched abundant transcript 1 (lnc‐NEAT1) regulates endothelial cell functions, CD4 + T cell regulation and chronic inflammation related to coronary heart disease (CHD). Then this case‐control study measured lnc‐NEAT1 expression in CHD patients, aiming to explore its clinical value in CHD management. Methods Totally, 120 documented CHD patients and 120 suspected subjects without CHD diagnosis as controls were enrolled. Plasma lnc‐NEAT1 was detected by RT‐qPCR in all participants, plasma inflammatory cytokines were assessed by ELISA, T helper (Th) 1, Th2, Th 17 cell proportions in CD4 + T cells were analyzed by flow cytometric analysis in CHD patients, respectively. Results Lnc‐NEAT1 was higher in CHD patients than in controls ( p < 0.001). In CHD patients, lnc‐NEAT1 positively associated with Gensini score ( r = 0.323, p < 0.001). Besides, lnc‐NEAT1 positively correlated with tumor necrosis factor‐α ( r = 0.271, p = 0.003), interleukin (IL)‐1β ( r = 0.216, p = 0.018), IL‐6 ( r = 0.217, p = 0.018) and IL‐17 ( r = 0.292, p = 0.001); meanwhile, it was positively associated with the percentage of Th 17 cells ( r = 0.384, p = 0.002). However, no correlation was found in lnc‐NEAT1 with the percentage of Th1 or Th2 cells (all p > 0.05). Moreover, lnc‐NEAT1 was correlated with higher hyperuricemia prevalence ( p = 0.028), increased total cholesterol ( r = 0.263, p = 0.004) and low‐density lipoprotein cholesterol ( r = 0.261, p = 0.004), but was not associated with other characteristics (all p > 0.05). Conclusion Lnc‐NEAT1 correlates with Th17 cells and proinflammatory cytokines, also reflects stenosis degree and cholesterol level in CHD patients, which potentially improves the management of CHD patients.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2022) conducted a case-control in Coronary heart disease (n=240). lnc-NEAT1 expression vs. Subjects without CHD (controls) was evaluated on Diagnostic value of lnc-NEAT1 expression for discriminating CHD patients from controls (AUC 0.866, 95% CI 0.822-0.910, p=<0.001). Plasma lnc-NEAT1 expression was significantly higher in patients with coronary heart disease compared to controls and effectively discriminated between the two groups with an AUC of 0.866.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: